Close Menu

Spanish National Research Council

Study leaders have now partnered with pharma to show the assay's utility with the hope that it can used to identify patients at risk of cancer recurrence.

Using genomic data for hundreds of ancient Europeans, research teams retraced the spread of the Beaker complex culture as well as interactions between pastoralists and hunter-gatherers.

Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.

NEW YORK (GenomeWeb News) – Some cases of premature ovarian failure and related infertility may be due to mutations affecting proteins involved in meiosis, according to a pair of exome sequencing reports published in the New England Journal of Medicine yesterday.

NEW YORK (GenomeWeb Daily News) – An international team of researchers sequenced the genome and characterized a handful of alleles from a Mesolithic skeleton dating back some 7,000 years.

Qiagen will distribute a new amplification buffer from Sygnis Pharma under a licensing agreement between the companies, Sygnis said today.

German pharmaceutical company Sygnis Pharma said today that it is acquiring X-Pol Biotech, a subsidiary of Spanish biotechnology holding company Genetrix, in a bid to further develop and market X-Pol's DNA sequencing technologies and products, including its DNA polymerase technol

An ethics committee at the Spanish National Research Council is reportedly calling for researchers to retract a paper published last year describing an array-based approach for measuring metabolite levels and enzyme activity.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.